What’s new in AI healthcare? DeepTek’s Chest X-ray AI now identifies 20+ lung conditions with EU MDR certification!

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

"This FDA Breakthrough Device Designation underscores the potential of our computational pathology platform to enable more personalised treatment decisions for people with cancer,” said Susan ...

There are multiple techniques for performing liver biopsies via a celiotomy. Ultimately, the choice of technique is at the ...

While recent data suggest that some hospital and health system finances have experienced modest stabilization from historic ...